Synopsis
Synopsis
0
USDMF
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
| Molecular Weight | 1135.0 g/mol |
|---|---|
| Molecular Formula | C42H70O35 |
| XLogP3 | -15 |
| Hydrogen Bond Donor Count | 21 |
| Hydrogen Bond Acceptor Count | 35 |
| Rotatable Bond Count | 7 |
| Exact Mass | 1134.3697639 g/mol |
| Monoisotopic Mass | 1134.3697639 g/mol |
| Topological Polar Surface Area | 554 Ų |
| Heavy Atom Count | 77 |
| Formal Charge | 0 |
| Complexity | 1480 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 21 |
| Undefined Atom Stereocenter Count | 14 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
51
PharmaCompass offers a list of Betadex API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Betadex manufacturer or Betadex supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Betadex manufacturer or Betadex supplier.
PharmaCompass also assists you with knowing the Betadex API Price utilized in the formulation of products. Betadex API Price is not always fixed or binding as the Betadex Price is obtained through a variety of data sources. The Betadex Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A CAVAMAX W7 Pharma manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of CAVAMAX W7 Pharma, including repackagers and relabelers. The FDA regulates CAVAMAX W7 Pharma manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. CAVAMAX W7 Pharma API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A CAVAMAX W7 Pharma supplier is an individual or a company that provides CAVAMAX W7 Pharma active pharmaceutical ingredient (API) or CAVAMAX W7 Pharma finished formulations upon request. The CAVAMAX W7 Pharma suppliers may include CAVAMAX W7 Pharma API manufacturers, exporters, distributors and traders.
click here to find a list of CAVAMAX W7 Pharma suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A CAVAMAX W7 Pharma CEP of the European Pharmacopoeia monograph is often referred to as a CAVAMAX W7 Pharma Certificate of Suitability (COS). The purpose of a CAVAMAX W7 Pharma CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of CAVAMAX W7 Pharma EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of CAVAMAX W7 Pharma to their clients by showing that a CAVAMAX W7 Pharma CEP has been issued for it. The manufacturer submits a CAVAMAX W7 Pharma CEP (COS) as part of the market authorization procedure, and it takes on the role of a CAVAMAX W7 Pharma CEP holder for the record. Additionally, the data presented in the CAVAMAX W7 Pharma CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the CAVAMAX W7 Pharma DMF.
A CAVAMAX W7 Pharma CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. CAVAMAX W7 Pharma CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of CAVAMAX W7 Pharma suppliers with CEP (COS) on PharmaCompass.
CAVAMAX W7 Pharma Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of CAVAMAX W7 Pharma GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right CAVAMAX W7 Pharma GMP manufacturer or CAVAMAX W7 Pharma GMP API supplier for your needs.
A CAVAMAX W7 Pharma CoA (Certificate of Analysis) is a formal document that attests to CAVAMAX W7 Pharma's compliance with CAVAMAX W7 Pharma specifications and serves as a tool for batch-level quality control.
CAVAMAX W7 Pharma CoA mostly includes findings from lab analyses of a specific batch. For each CAVAMAX W7 Pharma CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
CAVAMAX W7 Pharma may be tested according to a variety of international standards, such as European Pharmacopoeia (CAVAMAX W7 Pharma EP), CAVAMAX W7 Pharma JP (Japanese Pharmacopeia) and the US Pharmacopoeia (CAVAMAX W7 Pharma USP).
